To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

At the CEF/ETF Income Laboratory , we manage ~8%-yielding closed-end fund ( CEF ) and exchange-traded fund (ETF) portfolios to make income investing easy for you. Check out what our members have to say about our service.Juan de la Hoz has worked as a fixed income trader, financial analyst, operations analyst, and as an economics professor. He has experience analyzing, trading, and negotiating fixed-income securities, including bonds, money markets, and interbank trade financing, across markets and currencie ...

Core Viewpoint - The current investment landscape is characterized by extreme stock valuations, making it essential for investors to engage in stock picking to identify undervalued companies with significant upside potential [1] Group 1: Investment Strategy - The focus is on researching relatively unknown companies that offer attractive risk/reward profiles, which may lead to outsized returns despite the associated risks [1] - The investment approach emphasizes that the companies discussed are mostly speculative opportunities and should not constitute core holdings in a diversified portfolio [1] Group 2: Market Conditions - The current market presents numerous opportunities and information, making it an exciting time for investors [1] - The extreme valuations of many stocks necessitate a more diligent approach to investment selection [1]

I'm at about 30 years persevering as a “professional bear.” My lucky break came in late-1989, when I was hired by Gordon Ringoen to be the trader for his short-biased hedge fund in San Francisco. Working as a short-side trader, analyst and portfolio manager during the great nineties bull market – for one of the most brilliant individuals I’ve met – was an exciting, demanding and, in the end, a grueling and absolutely invaluable learning experience. Later in the nineties, I had stints at Fleckenstein Capital ...

Thanks to our global coverage we've ramped up our global macro commentary on our marketplace service here on Seeking Alpha, The Value Lab . We focus on long-only value ideas, where we try to find international mispriced equities and target a portfolio yield of about 4% . We've done really well for ourselves over the last 5 years, but it took getting our hands dirty in international markets. If you are a value-investor, serious about protecting your wealth, us at the Value Lab might be of inspiration.The iSh ...

PresentationMichael SteinmannPresident, CEO & Director Thanks, and good afternoon, everyone. Always a pleasure to be here. Normally, it's the nice warm day out there. It's colder here than Vancouver looks like, but I'm sure the sun will come back. Great to give you an update on Pan American Silver. A lot has changed over the last year, of course. And let me just step in there and show you on the plan. Of course, I will use forward-looking statements in my presentation. And we can spend some time here on the ...

The BNY Mellon Global Infrastructure Income ETF ( BKGI ) is a relatively new (formed in November 2022) and small ETF, with assets under management of just over $700 million. As of the end of January 2026, it is diversified across 33 holdings. It has an expense ratioAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives ...

Donovan Jones is an IPO research specialist with 15 years of experience analyzing investment opportunities for U.S. IPOs.He also leads the investing group IPO Edge, which offers actionable information on growth stocks through first-look IPO filings, previews on upcoming IPOs, an IPO calendar for tracking what’s on the horizon, a database of U.S. IPOs, and a guide to IPO investing to walk you through the entire IPO lifecycle - from filing to listing to quiet period and lockup expiration dates. Learn moreAnal ...

iREIT+HOYA Capital is the premier income-focused investing service on Seeking Alpha. Our focus is on income-producing asset classes that offer the opportunity for sustainable portfolio income , diversification , and inflation hedging . Get started with a Free Two-Week Trial and take a look at our top ideas across our exclusive income-focused portfolios.It’s common investment knowledge that energy is a volatile industry, going through boom and bust cycles, as we have seen with oil prices over the past decade ...

Core Viewpoint - Gossamer Bio Inc. announced the top line results from the PROSERA Phase III study of seralutinib for pulmonary arterial hypertension, indicating significant progress in their clinical development pipeline [2]. Group 1: Study Results - The PROSERA study is a Phase III clinical trial focused on seralutinib, which targets pulmonary arterial hypertension [2]. - The results from the study were released in a press release available on the company's Investors section of their website [2]. Group 2: Company Leadership - The call featured Gossamer executives including COO & CFO Bryan Giraudo, along with other key team members such as Faheem Hasnain, Dr. Richard Aranda, Bob Smith, Dr. Rob Roscigno, and Caryn Peterson [2].